Biomendex

We at Biomendex develop and manufacture adaptable synthetic bone substitute materials for bone regeneration. Our invention, Adaptos, is the first bioactive bone graft substitute that surgeons can cut, shape or squeeze into place. It is the only bone graft substitute that mimics bone by being resilient and bioactive. Our mission in Biomendex is to change the way bone voids are treated. We believe that delivering versatile and better working medical devices to operating theaters is an essential factor in improving surgical outcomes and minimizing the operational risks in bone regeneration. We believe in freedom to operate

Bonegrafts,medical device,tissue engineering,bone regeneration,biomaterials,biodegradation,bioresorbtion,bone,bone surgery,veterinary orthopaedic surgery,and orthopaedic surgery

Biomendex operates in the Medical equipment manufacturing industry.

Biomendex's revenue is 11m - 100m

Biomendex has 11 - 50 employees.